A Study to Assess New Participant's Perspectives Beyond Clinical Efficacy of Monoclonal Antibody-Based Relapsing Remitting Multiple Sclerosis (RRMS) Treatments
Clinical trial NCT06127095 · COMPLETED
Trial details
- NCT number
- NCT06127095
- Sponsor
- Biogen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-24
- Primary completion
- 2024-11-28
- Enrollment
- 474
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.